ACP Journal Club. Meta-analysis: aspirin reduces risk for colon cancer and related mortality at 20 years, particularly when taken for ≥ 5 years
- PMID: 21403066
- DOI: 10.7326/0003-4819-154-6-201103150-02003
ACP Journal Club. Meta-analysis: aspirin reduces risk for colon cancer and related mortality at 20 years, particularly when taken for ≥ 5 years
Comment on
-
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials.Lancet. 2010 Nov 20;376(9754):1741-50. doi: 10.1016/S0140-6736(10)61543-7. Epub 2010 Oct 21. Lancet. 2010. PMID: 20970847
Similar articles
-
ACP Journal Club. Individual-patient meta-analysis: daily aspirin reduces risk for incident cancer with distant metastasis.Ann Intern Med. 2012 Jul 17;157(2):JC2-2, JC2-3. doi: 10.7326/0003-4819-157-2-201207170-02003. Ann Intern Med. 2012. PMID: 22801695 No abstract available.
-
ACP Journal Club. Review: daily aspirin reduces short-term risk for cancer and cancer mortality.Ann Intern Med. 2012 Jul 17;157(2):JC2-2, JC2-3. doi: 10.7326/0003-4819-157-2-201207170-02002. Ann Intern Med. 2012. PMID: 22801694 No abstract available.
-
ACP Journal Club. Individual patient meta-analysis: taxane plus anthracycline reduces mortality from early breast cancer.Ann Intern Med. 2012 Jun 19;156(12):JC6-4. doi: 10.7326/0003-4819-156-12-201206190-02004. Ann Intern Med. 2012. PMID: 22711105 No abstract available.
-
ACP Journal Club. Meta-analysis: adjuvant tamoxifen reduces recurrence and death at 15 years in ER-positive early breast cancer.Ann Intern Med. 2012 Mar 20;156(6):JC3-4. doi: 10.7326/0003-4819-156-6-201203200-02004. Ann Intern Med. 2012. PMID: 22431690 No abstract available.
-
The aspirin controversy in primary prevention.Curr Opin Cardiol. 2012 Sep;27(5):499-507. doi: 10.1097/HCO.0b013e328356ae95. Curr Opin Cardiol. 2012. PMID: 22874127 Review.
Publication types
LinkOut - more resources
Full Text Sources